BRCA1 inhibited the estradiol-inducible transcriptional activity of ERα in breast and prostate cancer cells whereas cancer-associated BRCA1-mutant cells did not exhibit depressed ERα activity (75, 76). The gene discussed is ESR1; the disease is prostate carcinoma.